Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 23,750 shares at $39.01 ($940K) on 2021-09-08, disclosed to the SEC on 2021-09-09.
Open-market sale of $940k ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.71 | 9,375 | $372K | 39.6% |
| 2 | $39.71 | 9,375 | $372K | 39.6% |
| 3 | $39.01 | 5,000 | $195K | 20.8% |
| Total | $39.56 avg | 23,750 | $940K | 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |
| ADPT | SELL | 2021-07-08 | $1.2M | — | Filing → |